PRTG
Income statement / Annual
Last year (2024), Portage Biotech Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Portage Biotech Inc.'s net income was -$75.34 M.
See Portage Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$54,000.00 |
$1,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$54,000.00 |
-$1,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$12.54 M
|
$8.21 M
|
$6.77 M
|
$7.31 M
|
$4.11 M
|
$762,000.00
|
$561,000.00
|
$32.45 M
|
$4.58 M
|
$2.93 M
|
| General & Administrative
Expenses |
$5.66 M
|
$8.36 M
|
$8.82 M
|
$5.13 M
|
$1.87 M
|
$1.87 M
|
$1.55 M
|
$2.56 M
|
$4.52 M
|
$1.30 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.66 M
|
$8.36 M
|
$8.82 M
|
$5.13 M
|
$1.87 M
|
$1.87 M
|
$1.55 M
|
$2.56 M
|
$4.52 M
|
$1.30 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
-$1.26 M |
$0.00 |
$134,000.00 |
$116,000.00 |
$484,519.00 |
$95,336.00 |
$91,686.00 |
| Operating Expenses |
$18.20 M |
$16.58 M |
$15.59 M |
$12.44 M |
$5.98 M |
$2.76 M |
$2.23 M |
$35.49 M |
$9.19 M |
$4.32 M |
| Cost And Expenses |
$18.25 M |
$16.58 M |
$15.59 M |
$12.44 M |
$5.98 M |
$2.76 M |
$2.23 M |
$35.49 M |
$9.19 M |
$4.32 M |
| Interest Income |
$274,000.00 |
$217,000.00 |
$43.00 |
$177.00 |
$11,000.00 |
$111,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$32,000.00 |
$9,000.00 |
$43,000.00 |
$177,000.00 |
$557,000.00 |
$88,000.00 |
$32,000.00 |
$552,422.00 |
$7,384.00 |
$20,036.00 |
| Depreciation &
Amortization |
$54,000.00
|
$1,000.00
|
$15.59 M
|
$12.24 M
|
$5.98 M
|
$2.69 M
|
$168,000.00
|
$168,000.00
|
$9.19 M
|
$1.22 M
|
| EBITDA |
-$18.20 M
|
-$16.62 M
|
-$15.65 M
|
-$14.19 M
|
-$5.95 M
|
-$2.82 M
|
-$2.23 M
|
-$49.95 M
|
-$9.19 M
|
-$4.32 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$67.44 M
|
-$106.15 M
|
$771,000.00
|
-$2.45 M
|
$894,000.00
|
-$853,000.00
|
$126.00 M
|
$35.40 M
|
-$7,384.00
|
-$4,122.00
|
| Income Before Tax |
-$85.70 M |
-$122.52 M |
-$14.82 M |
-$14.89 M |
-$5.08 M |
-$3.59 M |
$123.74 M |
-$641,274.00 |
-$9.20 M |
-$4.34 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$10.55 M |
-$17.86 M |
$4.35 M |
$2.30 M |
$2.17 M |
-$217,000.00 |
-$126.00 M |
-$52.34 M |
-$3.49 M |
-$1.22 M |
| Net Income |
-$75.34 M |
-$104.61 M |
-$19.17 M |
-$17.19 M |
-$7.25 M |
-$2.64 M |
$123.74 M |
$16.30 M |
-$5.71 M |
-$3.12 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-3.7 |
-6.49 |
-1.47 |
-1.47 |
-0.66 |
-0.55 |
46.21 |
6.42 |
-2.38 |
-1.61 |
| EPS Diluted |
-3.7 |
-6.49 |
-1.47 |
-1.47 |
-0.66 |
-0.55 |
45.89 |
5.99 |
-2.38 |
-1.61 |
| Weighted Average Shares
Out |
$20.34 M
|
$16.12 M
|
$13.06 M
|
$11.73 M
|
$10.95 M
|
$4.82 M
|
$2.68 M
|
$2.54 M
|
$2.40 M
|
$1.93 M
|
| Weighted Average Shares
Out Diluted |
$20.34 M
|
$16.12 M
|
$13.06 M
|
$11.73 M
|
$10.95 M
|
$4.82 M
|
$2.70 M
|
$2.72 M
|
$2.40 M
|
$1.93 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
